DIN 02285533 — KALETRA 50 MG; 200 MG
KALETRA is a tablet of Lopinavir / Ritonavir marketed by ABBVIE CORPORATION. The full Lopinavir / Ritonavir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02285533
- Brand name
- KALETRA
- Active ingredient
- Lopinavir / Ritonavir
- Strength
- 50 MG; 200 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- ABBVIE CORPORATION
- Health Canada status
- MARKETED
- Drug class
- HIV protease inhibitor combination (ritonavir-boosted lopinavir)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Lopinavir / Ritonavir products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02312301 | KALETRA | 25 MG; 100 MG | TABLET | ABBVIE CORPORATION | MARKETED |
| 02243644 | KALETRA | 400 MG; 100 MG | SOLUTION | ABBVIE CORPORATION | MARKETED |